Speakers |
ASCO 2022: Phase II S1800A TrialOverall survival from a randomized study for advanced NSCLC previously treated with immunotherapy |
| Watch the Video
|
| Listen to Audio Only
|
ASCO 2022: Results from Cohorts 3, 4, 5 of the COSMIC-021 StudyCabozantinib (C) in combination with atezolizumab (A) in urothelial carcinoma (UC) |
| Watch Video
|
| Audio Only
|
ASCO 2022: Phase 2/3 QUILT-3.032 TrialFinal clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive CIS and papillary NMIBC |
| Watch Video
|
| Audio Only
|
| Create Your Own Account
|
|
Interested In Advertising With Us? |